is bpc-157 effective for athletes and injury treatment: Science, safety, and legal concerns FDA panel votes to ease

10.1021/acs.jmedchem.4c01257 68 GegiaM.WintersN.BenedettiA.van SoolingenD.MenziesD

Russell AL, Kennedy AM, Spuches AM, Gibson WS, Venugopal D, Klapper D, Srouji AH, Bhonsle JB, Hicks RP (2011) Determining the effect of the incorporation of unnatural amino acids into antimicrobial peptides on the interactions with zwitterionic and anionic membrane model systems

(2) Clarification for identifying single-dose containers In the CY 2023 PFS final rule (87 FR 69719), we finalized that the definition of refundable drug would apply to drugs paid under Medicare Part B (that is, under any payment methodology) that are described in FDA-approved labeling as being supplied in a single-dose container or single-use package

Its a circular problem, and its not entirely unfair to point that out